Edition:
United States

LeMaitre Vascular Inc (LMAT.OQ)

LMAT.OQ on NASDAQ Stock Exchange Global Market

29.48USD
4:00pm EDT
Change (% chg)

$-0.46 (-1.54%)
Prev Close
$29.94
Open
$29.98
Day's High
$29.98
Day's Low
$29.18
Volume
45,583
Avg. Vol
57,106
52-wk High
$33.15
52-wk Low
$13.53

Latest Key Developments (Source: Significant Developments)

LeMaitre Vascular Inc Q1 earnings per share $0.16
Wednesday, 26 Apr 2017 04:05pm EDT 

April 26 (Reuters) - LeMaitre Vascular Inc ::LeMaitre Q1 2017 record sales $24.1 mm (+19%), net income $3.2 mm (+49%).Q1 earnings per share $0.16.Qtrly sales of $24.1 million up 19% versus. Q1 2016.Sees Q2 sales $25.4 million; sees Q2 earnings per share $0.17.Sees FY 2017 sales $100.5 million; sees FY earnings per share $0.70 .Q1 earnings per share view $0.13, revenue view $23.5 million -- Thomson Reuters I/B/E/S.Q2 earnings per share view $0.17, revenue view $25.0 million -- Thomson Reuters I/B/E/S.FY2017 earnings per share view $0.66, revenue view $99.0 million -- Thomson Reuters I/B/E/S.  Full Article

Lemaitre sees q2 earnings per share $0.70
Wednesday, 26 Apr 2017 04:05pm EDT 

April 26 (Reuters) - Lemaitre Vascular Inc :Lemaitre q1 2017 record sales $24.1 mm (+19%), net income $3.2 mm (+49%).Q1 earnings per share $0.16.Qtrly sales of $24.1 million up 19% versus. Q1 2016.Lemaitre Vascular Inc sees q2 sales $25.4 million; sees q2 earnings per share $0.17.Lemaitre Vascular Inc sees fy 2017 sales $100.5 million; sees q2 earnings per share $0.70.Q1 earnings per share view $0.13, revenue view $23.5 million -- Thomson Reuters I/B/E/S.Q2 earnings per share view $0.17, revenue view $25.0 million -- Thomson Reuters I/B/E/S.Fy2017 earnings per share view $0.66, revenue view $99.0 million -- Thomson Reuters I/B/E/S.  Full Article

Lemaitre Vascular Q4 earnings per share $0.13
Tuesday, 21 Feb 2017 04:05pm EST 

Lemaitre Vascular Inc : Q4 earnings per share $0.13 . Q4 earnings per share view $0.15 -- Thomson Reuters I/B/E/S . Qtrly sales of $23.3 million, up 14% versus. Q4 2015 .Sees Q1 sales of $23.5 million, sees 2017 sales of $99.0 million.  Full Article

Lemaitre Vascular Q3 EPS $0.17
Wednesday, 26 Oct 2016 04:05pm EDT 

Lemaitre Vascular Inc : Q3 earnings per share $0.17 . Q3 earnings per share view $0.15 -- Thomson Reuters I/B/E/S . Qtrly sales of $23.2 million, up 22 pct versus. Q3 2015 . Sees 2016 sales $89.0 million (+14 pct reported, +12 pct organic) . FY2016 revenue view $88.3 million -- Thomson Reuters I/B/E/S .Q3 revenue view $22.2 million -- Thomson Reuters I/B/E/S.  Full Article

Lemaitre Vascular says Q2 earnings per share $0.14
Wednesday, 27 Jul 2016 04:05pm EDT 

Lemaitre Vascular Inc : Lemaitre q2 2016 record sales $22.4mm (+13%), record op. Income $3.8mm (+35%) . Q2 earnings per share $0.14 . Q2 earnings per share view $0.11 -- Thomson Reuters I/B/E/S .Lemaitre vascular inc qtrly sales of $22.4 million, up 13 percent.  Full Article

LeMaitre Vascular, Inc gives Q2 2016 guidance; raises FY 2016 guidance
Monday, 2 May 2016 04:05pm EDT 

LeMaitre Vascular, Inc:Expects Q2 2016 sales of $21.6 mln, a reported increase of 9% vs. Q2 2015.expects Q2 2016 gross margin of 69.0%.expects Q2 2016 operating income of $3.2 mln (15% operating margin), an increase of 15% vs. Q2 2015.Increased FY 2016 sales guidance to $85.7 mln, a reported increase of 9% vs. 2015.expects FY 2016 gross margin of 70.5%.increased FY 2016 operating income guidance to $14.3 mln (17% operating margin), a 24% increase vs. 2015.  Full Article

LeMaitre Vascular acquires ProCol Vascular Bioprosthesis
Friday, 18 Mar 2016 02:30pm EDT 

LeMaitre Vascular:Has acquired the ProCol Vascular Bioprosthesis product line from Hancock Jaffe Laboratories Inc for $665,000 plus a three year royalty.In conjunction with the acquisition, Hancock Jaffe Laboratories will provide manufacturing transition services to LeMaitre Vascular from its production facility in Irvine, CA for up to five years.  Full Article

LeMaitre Vascular, Inc gives Q4 2015 guidance above analysts' estimates; raises FY 2015 guidance
Tuesday, 27 Oct 2015 04:00pm EDT 

LeMaitre Vascular, Inc:Sees Q4 2015 sales of $20.1 million.Sees Q4 2015 operating income of $2.6 million.Increases its FY 2015 sales guidance to $78.0 million.Increases its FY 2015 operating income guidance to $11.0 million.Q4 2015 revenue of $19.7 million and EBIT of $2.3 million - Thomson Reuters I/B/E/S.FY 2015 revenue of $77.4 million and EBIT of $9.5 million - Thomson Reuters I/B/E/S.  Full Article

LeMaitre Vascular announces registration of TRIVEX System in China
Friday, 16 Oct 2015 04:01pm EDT 

LeMaitre Vascular, Inc:Says China's Food and Drug Administration has approved the registration of the Company's TRIVEX System.Says registration triggers a previously signed five-year, $7.8 million distribution agreement with LeMaitre Vascular's exclusive TRIVEX distributor in China.  Full Article

LeMaitre Vascular Inc declares dividend
Thursday, 30 Jul 2015 06:05am EDT 

LeMaitre Vascular Inc:Approves a quarterly dividend of $0.04/share of common stock.Says the dividend will be paid Sept. 3 to shareholders of record on Aug. 20.  Full Article

More From Around the Web

BRIEF-LeMaitre Vascular Inc Q1 earnings per share $0.16

* LeMaitre Q1 2017 record sales $24.1 mm (+19%), net income $3.2 mm (+49%)